News

Parkinson’s Disease Foundation’s New Online Educational Series Highlights Disorder’s Under-Recognized Aspects

The first of a series of six new free online PD ExpertBriefings seminars has been launched by the Parkinson’s Disease Foundation with more practical tips for people living with Parkinson’s and continuing education for health professionals about under-recognized aspects of the progressive neurological disorder. “Many people living with Parkinson’s…

Innovative Nano-Technology Teaches Parkinson’s Damaged Neurons To Heal Themselves

Researchers from the UNC Eshelman School of Pharmacy are using patients’ own immune cells to enhance the brain’s ability to heal damaged nerve fibers caused by degenerative neurological disorders like Parkinson’s disease. This innovative research is being conducted in the laboratory of Dr. Elena V Batrakova, PhD, Associate Professor at the UNC Eshelman…

ACADIA Pharmaceuticals Files New Drug Application for NUPLAZID In Parkinson’s Disease Psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company specialized in the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, has just announced it has filed for a New Drug Application with the US Food and Drug Administration for NUPLAZID (pimavanserin) for the treatment of psychosis associated…

Study Finds High Frequency of Parkinsonism in Adults With Autism

A study entitled “High rates of parkinsonism in adults with autism”, published 30 August, 2015 in the Journal of Neurodevelopmental Disorders, has established a correlation between autism and parkinsonian motor signs. Autism spectrum disorder (ASD) is diagnosed in approximately 1.5% of children in the…